Epigenetic drugs show promise as antivirals

Epigenetic drugs show promise as antivirals

Some epigenetic pharmaceuticals have the potential to be used as broad spectrum antivirals, according to a new study. The study demonstrated that histone methyltransferases EZH2/1 inhibitors, which are being used in cancer clinical trials, have activity against a variety of viruses, including herpes simplex virus (HSV).

8
Like
Save

Comments

Comments are disabled for this post.